AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7507135
Drug: Capsaicin cream
RxNorm normalized name: CAPSAICIN 0.1 g in 100 g TOPICAL CREAM [Capsaicin Cream]
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Capsaicin cream 0.025%, 0.5% or 1.0% applied three times daily for 4 weeks
Trial: 8349327
Drug: Losartan (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (100 mg)
Trial: 31310277
Drug: Intravenous Acetaminophen
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Acetaminophen
Trial: 23216584
Drug: Olmesartan/Amlodipine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan/Amlodipine combination (20 mg/5 mg)
Trial: 19815148
Drug: Light buccally
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Light buccally directed orthodontic force of 25 g
Trial: 19216814
Drug: WHEY+CAS (casein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WHEY+CAS (casein and whey proteins mixture, 22 g protein, 836 kJ)
Trial: 19216814
Drug: CAS (casein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAS (casein only, 22 g protein, 836 kJ)
Trial: 11902300
Drug: Intravenous ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ondansetron at 0.15 mg/kg
Trial: 11902300
Drug: Intravenous ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ondansetron at 0.45 mg/kg
Trial: 20519076
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (CT)
Trial: 16752024
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg bid after a 400 mg loading dose
Trial: 16752024
Drug: Diclofenac SR
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac SR 75 mg bid
Trial: 29021235
Drug: morphine +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: morphine + ibuprofen
Trial: 22288725
Drug: Low-dose azithromycin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose azithromycin
Trial: 23291349
Drug: Low-dose azithromycin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose azithromycin (in non-eosinophilic severe asthma)
Trial: 3669078
Drug: Combination Treatment
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination Treatment
Trial: 11699827
Drug: Controlled-release tablets
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release tablets of diclofenac sodium with HPMC and NaCMC (1:2:1 ratio)
Trial: 9872487
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol patches (50 microg daily) with intrauterine system releasing 20 microg of levonorgestrel daily
Trial: 7520396
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment alone
Trial: 7520396
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment with frequent ejaculation
Trial: 3123302
Drug: Elemental diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elemental diet therapy (administered nocturnally, at home, by continuous nasogastric infusion)
Trial: 31994819
Drug: Conventional medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional medical therapy (control group)
Trial: 21732212
Drug: Daily self-weighing
RxNorm normalized name: DAILY SELF DISCOVERY SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily self-weighing
Trial: 30070045
Drug: Weekly weighing
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly weighing
Trial: 18806734
Drug: 23-valent vaccine
RxNorm normalized name: Pneumococcal 23-valent vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23-valent vaccine Pneumovax (0.5 mL administered intramuscularly)
Trial: 16860190
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment until hemoglobin < 9 g/dL)
Trial: 9375594
Drug: Pindolol 2.5
RxNorm normalized name: pindolol 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol 2.5 mg p.o. t.i.d. for 2 weeks
Trial: 3033968
Drug: Halothane anaesthesia
RxNorm normalized name: Halothane
DrugBank: Halothane (DB01159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Halothane anaesthesia with DA premedication (diazepam 0.25 mg kg‐1 and atropine 0.015 mg kg‐1)
Trial: 3033968
Drug: DMS premedication
RxNorm normalized name: DMS
DrugBank: Succimer (DB00566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DMS premedication (diazepam 0.5 mg kg‐1, morphine 0.15 mg kg‐1, scopolamine 0.01 mg kg‐1)
Trial: 29609475
Drug: Control Condition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control Condition (CC) - registered emotions five times daily for four weeks
Trial: 22762251
Drug: Astra Tech
RxNorm normalized name: carbamide peroxide
DrugBank: Carbamide peroxide (DB11129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Astra Tech TiOblast implants
Trial: 22762251
Drug: Brånemark turned
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brånemark turned implants
Trial: 18462354
Drug: Tosufloxacin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tosufloxacin (300 mg twice daily for 2 days, initial dose 2 hours prior to biopsy)
Trial: 1312588
Drug: Topotecan at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan at 1.5 mg/m2
Trial: 1312588
Drug: Topotecan at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan at 2.0 mg/m2
Trial: 1312588
Drug: Topotecan (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topotecan (all doses)
Trial: 6397365
Drug: Highly purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly purified semi-synthetic human insulin
Trial: 7037511
Drug: Highly purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Highly purified porcine insulin
Trial: 31203685
Drug: Proparacaine HCl
RxNorm normalized name: proparacaine HCl
DrugBank: Proparacaine (DB00807)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Proparacaine HCl ophthalmic solution 0.5% plus breast milk
Trial: 25388622
Drug: High-dose HAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose HAM flour cookie (33% wheat flour, 67% HAM flour)
Trial: 23659987
Drug: Fesoterodine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fesoterodine therapy
Trial: 15690267
Drug: Peribulbar block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peribulbar block with propofol infusion
Trial: 12567343
Drug: Intravenous meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous meperidine 1 mg/kg
Trial: 15690267
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl 2 microg/kg
Trial: 12826215
Drug: Mycophenolate mofetil
RxNorm normalized name: Mycophenolate Mofetil
DrugBank: Mycophenolate mofetil (DB00688)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mycophenolate mofetil (MMF) 2000 mg/d, CSA tapered to trough levels of 70 to 120 microg/L
Trial: 10499601
Drug: Intradermal needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal needle injection of rV-CEA (10^7 or 10^8 pfu)
Trial: 28253073
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) with fixed appliance; administered monthly using a Diode laser (980 nm, 1 W, continuous wave, total energy density = 150 J/cm2)
Trial: 25891006
Drug: Bendamustine 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendamustine 60 mg/m2, thalidomide 100 mg, dexamethasone 20 mg
Trial: 25891006
Drug: Bendamustine 100
RxNorm normalized name: bendamustine 100 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendamustine 100 mg/m2
Trial: 23263772
Drug: LY2599506 with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2599506 with dose titration
Trial: 23263772
Drug: LY2599506 with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2599506 with fixed dosing
Trial: 23263772
Drug: LY2599506 (50-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LY2599506 (50-400 mg BID)
Trial: 7688007
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (control group for elderly)
Trial: 3726509
Drug: Budesonide (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (2 X 800 micrograms daily)
Trial: 17721099
Drug: HAART (Highly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HAART (Highly Active Antiretroviral Therapy)
Trial: 14713758
Drug: Chemoprevention agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoprevention agents
Trial: 1858481
Drug: Intermittent diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent diazepam prophylaxis (few doses per year)
Trial: 3109069
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 50 mg/day
Trial: 6628518
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 100 mg/day
Trial: 6628518
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 1000 mg/day
Trial: 15818287
Drug: Gatifloxacin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gatifloxacin (10 mg/kg of body weight once daily for 10 days)
Trial: 23954024
Drug: Usual physiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Usual physiotherapy treatment
Trial: 19708635
Drug: C4‐5 facet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C4‐5 facet joint injection
Trial: 19708635
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (unilateral multifidi muscle injection)
Trial: 11923699
Drug: C2 (2-hr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C2 (2-hr post-dose cyclosporine monitoring)
Trial: 321992
Drug: Amoxicillin and
RxNorm normalized name: omeprazole, amoxicillin and rifabutin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin and flucloxacillin combination
Trial: 9607385
Drug: Irbesartan 100
RxNorm normalized name: Irbesartan
DrugBank: Irbesartan (DB01029)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Irbesartan 100 mg
Trial: 29545948
Drug: Trimethoprim (as
RxNorm normalized name: polymyxin B 10,000 UNT / trimethoprim (as trimethoprim sulfate) 0.1 % Ophthalmic Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim (as a weak CYP2C8 inhibitor)
Trial: 23765178
Drug: Pasireotide LAR
RxNorm normalized name: pasireotide LAR 20 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide LAR 20 mg
Trial: 22383336
Drug: Pasireotide LAR
RxNorm normalized name: pasireotide LAR 20 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide LAR 40 mg
Trial: 22383336
Drug: Pasireotide LAR
RxNorm normalized name: pasireotide LAR 20 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide LAR 60 mg
Trial: 24800725
Drug: Pasireotide LAR
RxNorm normalized name: pasireotide LAR 20 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pasireotide LAR (all doses)
Trial: 18548292
Drug: Two-visit indirect
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-visit indirect pulp treatment (IPT)
Trial: 15708100
Drug: Three-times daily
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Three-times daily tobramycin
Trial: 15708100
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily tobramycin
Trial: 15708100
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily tobramycin (in children)
Trial: 9502829
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg of pergolide
Trial: 9502829
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg of bromocriptine
Trial: 7694914
Drug: Fluoxetine (N
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (N = 6)
Trial: 329825
Drug: Practolol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Practolol (400 mg/day)
Trial: 25849646
Drug: Telmisartan (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (40 mg daily) with NaCl supplementation (100 mmol/24 h)
Trial: 25849646
Drug: Telmisartan (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (40 mg daily) with placebo
Trial: 25166287
Drug: Comprehensive medication
RxNorm normalized name: Easy Care First Aid Kit - Comprehensive KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comprehensive medication management services delivered postdischarge
Trial: 9539899
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with oral conjugated oestrogens (0.625 mg daily) and cyclic medroxyprogesterone acetate (10 mg daily on Day 14‐27 of each menstrual cycle)
Trial: 31705691
Drug: Intramuscular (i.m.)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (i.m.) administration of tolfenamic acid (4 mg/kg body weight)
Trial: 31705691
Drug: Intravenous (i.v.)
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (i.v.) administration of tolfenamic acid (4 mg/kg body weight)
Trial: 20039972
Drug: Weekly follow-up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly follow-up (Control group)
Trial: 18555912
Drug: Carbocisteine (1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbocisteine (1500 mg per day for 1 year)
Trial: 16162626
Drug: Intravenous vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous vitamin C with L-arginine
Trial: 16162626
Drug: Intravenous normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous normal saline with L-arginine
Trial: 16162626
Drug: Intravenous vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous vitamin C alone
Trial: 10632230
Drug: Nondirective supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nondirective supportive therapy
Trial: 2209307
Drug: Computer algorithms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer algorithms for insulin dosage adjustment
Trial: 2209307
Drug: Manual methods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual methods for insulin dosage adjustment
Trial: 2209307
Drug: Microprocessor device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microprocessor device for insulin dosage adjustment
Trial: 19118956
Drug: Dietary intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary intervention group (DG) receiving approximately 1200 mg of calcium and 7.5 microg of vitamin D3 per day via fortified dairy products and attending biweekly dietary and lifestyle intervention sessions
Trial: 3618443
Drug: Initial oral
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial oral provocation tests (OPT)
Trial: 31409486
Drug: Chemotherapy +
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy + Bevacizumab (BEV)
Trial: 31409486
Drug: Chemotherapy +
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy + Placebo (P)
Trial: 31409486
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (BEV and placebo)
Trial: 23025500
Drug: Positive stereotype
RxNorm normalized name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive stereotype exposure (e.g., 'Asians are good at math', 'women are nurturing')
Trial: 16904542
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy (CRT) without AVJ ablation
Trial: 26114393
Drug: N-Acetylcysteine added
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-Acetylcysteine added to University of Wisconsin solution
Trial: 26114393
Drug: Standard University
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard University of Wisconsin solution
Trial: 16749411
Drug: Active pulsed
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active pulsed electromagnetic therapy (PEMT)
Trial: 15090561
Drug: Clozapine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine (mean dosage 35.8 mg)
Trial: 10886488
Drug: Dexamethasone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (1 mg) suppression test
Trial: 7930246
Drug: Prourokinase (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prourokinase (60 mg or 80 mg monotherapy or 60 mg primed with 250,000 IU recombinant urokinase)
Trial: 31689482
Drug: Loxoprofen sodium
RxNorm normalized name: loxoprofen sodium dihydrate
DrugBank: Loxoprofen (DB09212)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Loxoprofen sodium (60 mg once orally)
Trial: 26634113
Drug: Placebo mouth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo mouth wash (15 ml)
Trial: 19092152
Drug: Alfuzosin 10
RxNorm normalized name: Alfuzosin 10mg Oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfuzosin 10 mg per day for 12 weeks
Trial: 15949728
Drug: Prostaglandin E1
RxNorm normalized name: Prostaglandin E1
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostaglandin E1 (PGE1) at doses of 0.05, 0.2, and 0.5 microg/kg/min
Trial: 15949728
Drug: Nitric oxide
RxNorm normalized name: Nitric Oxide
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nitric oxide (NO) at doses of 40, 60, and 80 ppm
Trial: 7995764
Drug: Conformal radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conformal radiation treatment
Trial: 7995764
Drug: Standard radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard radiation treatment
Trial: 29597305
Drug: Alcohol with
RxNorm normalized name: GNP 70% Isopropyl Alcohol with Wintergreen Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol with carbohydrate (25 g sucrose)
Trial: 29597305
Drug: Alcohol consumption
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alcohol consumption (20 g for males; 10 g for females)
Trial: 12544674
Drug: Constant‐estrogen, intermittent‐progestogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Constant‐estrogen, intermittent‐progestogen hormone replacement regimen (Ortho‐Prefest)
Trial: 11018622
Drug: Melanotan II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melanotan II (0.025 mg/kg)
Trial: 31091064
Drug: PRIMER protocol
RxNorm normalized name: Primor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PRIMER protocol (intrauterine PRP injection and subcutaneous G-CSF injection)
Trial: 31091064
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (first IVF/ICSI attempt without PRP or G-CSF injection)
Trial: 30030584
Drug: GLIF combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLIF combination chemotherapy (gemcitabine 800 mg/m2, levofolinate 100 mg/m2, irinotecan 80 mg/m2, 5-FU 1000 mg/m2)
Trial: 7782272
Drug: Phenelzine (monamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenelzine (monamine oxidase inhibitor)
Trial: 7782272
Drug: Brofaromine (reversible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brofaromine (reversible monamine oxidase inhibitor)
Trial: 7782272
Drug: Moclobemide (reversible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moclobemide (reversible monamine oxidase inhibitor)
Trial: 7782272
Drug: Fluvoxamine (serotonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine (serotonin selective reuptake inhibitor)
Trial: 7782272
Drug: Sertraline (serotonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (serotonin selective reuptake inhibitor)
Trial: 31881181
Drug: ADVIA Centaur®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ADVIA Centaur® XP system for insulin determination